Progenics Pharmaceuticals (PGNX)

Add to Watchlists
Create an Alert
5.53 +0.05  +0.91% NASDAQ Nov 21, 17:00 Delayed 2m USD

Progenics Pharmaceuticals Enterprise Value:

336.42M for Nov. 20, 2017
View 4,000+ financial data types
Browse...
View Full Chart

Progenics Pharmaceuticals Enterprise Value Chart

Export Data
Save Image
Print Image

Progenics Pharmaceuticals Historical Enterprise Value Data

View and export this data going back to 1997. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Nov. 20, 2017 336.42M
Nov. 17, 2017 344.15M
Nov. 16, 2017 347.67M
Nov. 15, 2017 330.80M
Nov. 14, 2017 322.37M
Nov. 13, 2017 334.32M
Nov. 10, 2017 344.86M
Nov. 9, 2017 351.18M
Nov. 8, 2017 350.48M
Nov. 7, 2017 342.05M
Nov. 6, 2017 365.94M
Nov. 3, 2017 382.80M
Nov. 2, 2017 368.05M
Nov. 1, 2017 363.13M
Oct. 31, 2017 386.32M
Oct. 30, 2017 380.69M
Oct. 27, 2017 387.02M
Oct. 26, 2017 363.13M
Oct. 25, 2017 380.70M
Oct. 24, 2017 375.07M
Oct. 23, 2017 408.10M
Oct. 20, 2017 401.78M
Oct. 19, 2017 408.10M
Oct. 18, 2017 419.34M
Oct. 17, 2017 413.72M
   
Oct. 16, 2017 411.61M
Oct. 13, 2017 419.34M
Oct. 12, 2017 436.91M
Oct. 11, 2017 457.99M
Oct. 10, 2017 453.78M
Oct. 9, 2017 450.97M
Oct. 6, 2017 466.43M
Oct. 5, 2017 481.18M
Oct. 4, 2017 475.56M
Oct. 3, 2017 486.80M
Oct. 2, 2017 494.53M
Sept. 29, 2017 452.79M
Sept. 28, 2017 449.28M
Sept. 27, 2017 431.01M
Sept. 26, 2017 415.55M
Sept. 25, 2017 433.11M
Sept. 22, 2017 424.68M
Sept. 21, 2017 424.68M
Sept. 20, 2017 423.98M
Sept. 19, 2017 439.44M
Sept. 18, 2017 434.52M
Sept. 15, 2017 383.22M
Sept. 14, 2017 372.68M
Sept. 13, 2017 379.01M
Sept. 12, 2017 375.49M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Advertisement

PGNX Enterprise Value Benchmarks

Companies
Aptevo Therapeutics -18.22M
AMAG Pharmaceuticals 860.09M
PDL BioPharma 156.29M

PGNX Enterprise Value Range, Past 5 Years

Minimum 30.47M Nov 28 2012
Maximum 724.75M Mar 15 2017
Average 307.53M

PGNX Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("PGNX", "enterprise_value")
  • Last 5 data points: =YCS("PGNX", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.